학술논문
Sofosbuvir plus ribavirin and sofosbuvir plus ledipasvir in patients with genotype 1 or 3 hepatitis C virus and severe renal impairment: a multicentre, phase 2b, non-randomised, open-label study
Document Type
Article
Author
Source
In The Lancet Gastroenterology & Hepatology October 2020 5(10):918-926
Subject
Language
ISSN
2468-1253